newsfilter
← Latest News
ACCESS Newswire·

MIRA Pharmaceuticals Enrolls First Subjects in Phase 1 Clinical Trial of Ketamir-2 for Neuropathic Pain

MIAMI, FLORIDA / ACCESS Newswire / April 1, 2025 / MIRA Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders,